MOTS-c: a peptide written inside the mitochondrial genome

MOTS-c is one of a small family of mitochondrial-derived peptides that metabolism researchers have studied closely since its first description in 2015. Most peptides in a cell are encoded by genes in the nucleus. This one is different: its instructions sit inside the mitochondrial genome, which makes it a useful probe for questions about how mitochondria signal to the rest of the cell. This note gathers the verified chemistry and the primary literature so a laboratory can work from confirmed numbers rather than secondhand summaries.

The name is shorthand for mitochondrial open reading frame of the twelve S ribosomal RNA. That points to where the sequence lives: a short open reading frame within the mitochondrial 12S rRNA gene, also called MT-RNR1. The encoded peptide is sixteen residues long. Reports describe it moving between the mitochondrion and the cytoplasm, and under metabolic stress relocating to the nucleus, where it associates with stress-response transcription factors.

Verified molecule

• Sequence: MRWQEMGYIFYPRKLR, a linear chain of sixteen standard L-amino acids.
• Molecular formula: C101H152N28O22S2.
• Molecular weight: 2174.6 g/mol.
• CAS number: 1627580-64-6.
• Origin: encoded within a short open reading frame in the mitochondrial 12S rRNA (MT-RNR1) region.

The two sulfur atoms in the formula come from the methionine residues near the start of the chain. The peptide also carries several basic residues, including the arginine and lysine cluster toward the carboxyl end, which gives it a net positive charge at neutral pH and shapes how it partitions in solution. These four identifiers, sequence, formula, mass, and CAS registry number, are the fields most worth checking against a supplier's paperwork, because small errors there tend to propagate into every downstream calculation.

How the peptide is thought to act

The most cited mechanism connects the peptide to AMP-activated protein kinase, usually shortened to AMPK, a central sensor that cells use to gauge their energy balance. When the ratio of AMP to ATP rises, AMPK activity climbs and the cell shifts toward pathways that regenerate energy. Research reports that this peptide pushes the sensor toward its active state, which links a mitochondrial signal to a well-mapped metabolic switch.

A second line of work ties the molecule to the folate and methionine one-carbon pathway. By influencing the flow of one-carbon units, it can alter the pool of intermediates that feed purine synthesis and AMP accumulation, offering one route by which it may reach AMPK. The picture that emerges is of a peptide that reads the state of the mitochondrion and relays it outward, rather than acting on a single fixed target.

Under metabolic stress such as glucose restriction or oxidative challenge, several studies describe the peptide moving into the nucleus and helping to regulate genes involved in antioxidant defense and metabolic balance. This dual location, both a cytoplasmic signal and a conditional nuclear regulator, is part of what makes it interesting to cell biologists.

It is worth stressing how much of this remains provisional. The peptide was described only in 2015, the number of independent groups working on it is still modest, and several proposed targets rest on a handful of studies. For a research program, that means it is better regarded as an open question than a settled tool, and results are best interpreted against the specific cell line, species, and conditions of each experiment.

What the primary literature reports

The founding paper came from Lee and colleagues in Cell Metabolism in 2015. Working in cell models and rodents, they characterized the peptide, mapped its link to the folate-methionine pathway and AMPK, and reported that it promotes metabolic homeostasis and reduces insulin resistance in the models tested. That study remains the anchor reference for the molecule's identity and proposed function.

A later report by Reynolds and colleagues in Nature Communications in 2021 described the molecule as an exercise-induced, mitochondrial-encoded regulator connected to age-dependent physical decline and muscle homeostasis in animal models. The work added a physiological dimension to the earlier biochemistry by tying activity to exercise and aging in preclinical systems. Both papers are laboratory studies in cells and animals, and neither establishes anything about use outside that research setting.

Working with the peptide in the laboratory

This peptide is typically supplied as a white lyophilized powder. Common practice is to reconstitute it in sterile water or bacteriostatic water, letting the liquid run down the vial wall rather than striking the powder directly, then swirling gently rather than shaking. Once in solution, splitting it into single-use aliquots limits freeze-thaw cycles, each of which can degrade a chain of this length.

For storage, lyophilized material is usually held at minus twenty degrees Celsius or colder, with reconstituted stock kept cold and used within a short window. Because the arginine and lysine residues make the molecule sensitive to certain buffers and surfaces, low-binding tubes and freshly prepared buffers help preserve recovery. A purity value from analytical HPLC and a matching mass from spectrometry are the two figures worth confirming on any certificate of analysis before an experiment begins.

Common questions

Is this a naturally occurring peptide?

Yes. The sequence is encoded within the mitochondrial 12S rRNA region of the human mitochondrial genome, and the peptide has been detected in cells and tissues. Synthetic material made for research reproduces that natural sixteen-residue sequence.

What sets it apart from peptides encoded in the nucleus?

Its coding sequence sits in the mitochondrial genome rather than the nuclear genome, which places it among the mitochondrial-derived peptides. That origin is why researchers study it as a signal that carries information about mitochondrial state to the wider cell.

Which references should I cite for its verified properties?

The two primary sources listed below are the standard citations: the 2015 Cell Metabolism paper that first characterized the peptide and its metabolic links, and the 2021 Nature Communications paper on its connection to exercise and aging in preclinical models.

References

1. Lee CH, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces insulin resistance. Cell Metabolism. 2015;21(3):443-454.
2. Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12(1):470.

For laboratory research use only. Not for human or veterinary use.